The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Activity of eribulin on skin metastases in breast cancer patients.
Nicla Maria La Verde
No relevant relationships to disclose
Anna Moretti
No relevant relationships to disclose
Teresa Gamucci
No relevant relationships to disclose
Karen Borgonovo
No relevant relationships to disclose
Mario Botta
No relevant relationships to disclose
Nello Salesi
No relevant relationships to disclose
Monica Zuradelli
No relevant relationships to disclose
Ida Pavese
No relevant relationships to disclose
Elena Barbieri
No relevant relationships to disclose
Elisabetta Cretella
No relevant relationships to disclose
Tiziana Saladino
No relevant relationships to disclose
Paola Varese
No relevant relationships to disclose
Gianfranco Addamo
No relevant relationships to disclose
Mariangela Ciccarese
No relevant relationships to disclose
Anna Iolanda Rispoli
No relevant relationships to disclose
Arianna Pellegrino
No relevant relationships to disclose
Lucia Mentuccia
No relevant relationships to disclose
Sheila Piva
No relevant relationships to disclose
Gabriella Farina
No relevant relationships to disclose
Massimo Di Maio
No relevant relationships to disclose